At the beginning of the COVID pandemic, we were hopeful that pre-existing immunity to the common cold could protect you from COVID, but new evidence suggests that sometimes the opposite can happen. A new University of Rochester ...
Mar 7, 2022
0
147
December 2021 marked the one-year anniversary of the first vaccine shots against SARS-CoV-2 administered outside of clinical trials. "When the vaccines were introduced, it was a game changer for our research efforts as well," ...
Mar 1, 2022
0
3
Cholera, a diarrheal disease caused by the highly transmissible bacteria Vibrio cholerae, kills tens of thousands of people each year worldwide. Current vaccines last only 2–5 years, and they don't work very well in young ...
Feb 16, 2022
0
8
Two studies in CJASN offer a better understanding of the effects of COVID-19 vaccination on individuals with kidney failure who are undergoing long-term dialysis.
Feb 10, 2022
0
2
The FDA will consider authorizing two doses of a COVID-19 vaccine for kids under five on an emergency basis, with the possibility for a third.
Feb 10, 2022
0
29
A new study by UCLA researchers and colleagues demonstrates that the Ebola vaccine known as rVSVΔG-ZEBOV-GP results in a robust and enduring antibody response among vaccinated individuals in areas of the Democratic Republic ...
Feb 8, 2022
1
407
The immune system develops a high-quality antibody response after three encounters with the coronavirus spike protein. These antibodies are also capable of neutralizing omicron efficiently. This applies to people who are ...
Feb 3, 2022
0
374
Certain blood cancer and arthritis patients have a significantly reduced antibody response to double COVID-19 vaccination in the first six months of being treated with a widely used drug, reveals a new study.
Jan 28, 2022
0
80
The American College of Physicians issued an updated Rapid, Living Practice Points on the antibody response to SARS-CoV-2 after initial infection and protection against reinfection with SARS-CoV-2. The new version, "What ...
Jan 26, 2022
0
10
In the journal Science, researchers from Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) and Charité–Universitätsmedizin Berlin present new findings on the immune response against the coronavirus SARS-CoV-2. ...
Jan 25, 2022
0
79
